MRNA is expected to report earnings to fall -745% to -355 cents per share on May 02

A.I.dvisor
at Tickeron.com
05/01/24
Loading...
MRNA - Moderna
Moderna Earnings Graph
Q1'24
Est.
$-3.55
Q4'23
Beat
by $1.54
Q3'23
Missed
by $7.63
Q2'23
Beat
by $0.32
Q1'23
Beat
by $1.94
The last earnings report on December 31 showed earnings per share of 55 cents, beating the estimate of -99 cents. P/B Ratio (3.048) is normal, around the industry mean (10.139). P/E Ratio (0.000) is within average values for comparable stocks, (115.202). MRNA's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.468). MRNA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.015). P/S Ratio (6.238) is also within normal values, averaging (226.762). With 3.21M shares outstanding, the current market capitalization sits at 42.22B.
View a ticker or compare two or three
MRNADaily Signal changed days agoGain/Loss if shorted
 
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of transformative medicines for patients

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
200 Technology Square
Phone
+1 617 714-6500
Employees
5600
Web
https://www.modernatx.com